Our Commitment to Safety and Transparency as We Study Our Investigational COVID-19 Vaccine Candidate
Learn More
Share
Oncology
Cancer. Diabetes. Autoimmune diseases. They're the common illnesses we have a better chance at fighting, thanks to Dr. Cantley's pioneering work. Learn more about his "magic molecule" research.
Siddhartha Mukherjee, M.D., made his name as an oncologist, researcher and Pulitzer Prize-winning writer. Now he's the scientific adviser of an immuno-oncology start-up that's tackling a rare form of leukemia. In an exclusive interview, he reveals his vision for the future of cancer treatments.
We retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of the disease to patients who may benefit most.
Some 20% of people diagnosed with the disease haven't touched a cigarette. For National Cancer Prevention Month, scientists who've dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson's venture capital division, which invests in dozens of companies each year. He shares what's on his radar for 2019.
Check out this fun interactive map for a glimpse at how the company is helping people on nearly every continent live healthier lives.
Who says you can't take your work home with you? For these men and women, their day jobs are just one facet of living a purpose-driven life to help others in truly impactful ways.
The doctor overseeing the company's new Lung Cancer Initiative reveals why it's uniquely qualified to work on thwarting the disease—and why he's uniquely qualified to oversee its efforts.
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
Preventative HIV innovations. Better access to oncology care. A mobile messaging service for moms. These are just a few of the initiatives underway—and Chairman and CEO Alex Gorsky sits down for an exclusive interview about all of them.
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company's fiscal future.
For Men's Health Month, school yourself on the latest screenings and treatments for this most common male cancer.
University and company researchers will work closely over the next five years to identify ways to better detect and treat the deadliest cancer in the world.
This month, the celebrity entrepreneur steps away from the shark tank to partner with Johnson & Johnson Innovation on a healthcare project that hits close to home.
From partnering with the Black AIDS Institute to reduce HIV infection rates to improving representation in clinical trials, learn how Johnson & Johnson has made it a mission to help address disparities in healthcare.
